126 related articles for article (PubMed ID: 11557742)
1. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells.
Shioji K; Kishimoto C; Sasayama S
Circ Res; 2001 Sep; 89(6):540-6. PubMed ID: 11557742
[TBL] [Abstract][Full Text] [Related]
2. [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].
Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
J Cardiol; 2005 Jun; 45(6):247-55. PubMed ID: 15991608
[TBL] [Abstract][Full Text] [Related]
3. Effects of immunoglobulin upon murine myocarditis caused by influenza A virus: superiority of intact type to F(ab')2 type.
Kishimoto C; Hiraoka Y; Takada H
J Cardiovasc Pharmacol; 2004 Jan; 43(1):61-7. PubMed ID: 14668569
[TBL] [Abstract][Full Text] [Related]
4. [The Fc region of immunoglobulin suppresses atherosclerosis in apolipoprotein E knockout mice].
Yuan ZY; Liu Y; Kishimoto C; Shioji K; Yokode M; Liu ZQ
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):489-93. PubMed ID: 12887764
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice.
Liu W; Nakamura H; Shioji K; Tanito M; Oka S; Ahsan MK; Son A; Ishii Y; Kishimoto C; Yodoi J
Circulation; 2004 Sep; 110(10):1276-83. PubMed ID: 15337697
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin treatment ameliorates myocardial injury in experimental autoimmune myocarditis associated with suppression of reactive oxygen species.
Kishimoto C; Nimata M; Okabe TA; Shioji K
Int J Cardiol; 2013 Jul; 167(1):140-5. PubMed ID: 22244481
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis.
Nimata M; Kishimoto C; Yuan Z; Shioji K
Mol Cell Biochem; 2004 Apr; 259(1-2):217-22. PubMed ID: 15124927
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin treatment suppressed adoptively transferred autoimmune myocarditis in severe combined immunodeficient mice.
Shioji K; Yuan Z; Kita T; Kishimoto C
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2619-25. PubMed ID: 15308483
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific tolerance induced by IL-10 gene modified immature dendritic cells in experimental autoimmune myocarditis in rats.
Li WM; Liu W; Gao C; Zhou BG; Yang SS; Wang Z; Zhang RH; Gan RT; Kong YH; Li Y
Chin Med J (Engl); 2006 Oct; 119(19):1646-52. PubMed ID: 17042978
[TBL] [Abstract][Full Text] [Related]
10. Emodin, a naturally occurring anthraquinone, ameliorates experimental autoimmune myocarditis in rats.
Song ZC; Wang ZS; Bai JH; Li Z; Hu J
Tohoku J Exp Med; 2012 Jul; 227(3):225-30. PubMed ID: 22791134
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats.
Maruyama S; Kato K; Kodama M; Hirono S; Fuse K; Nakagawa O; Nakazawa M; Miida T; Yamamoto T; Watanabe K; Aizawa Y
J Atheroscler Thromb; 2002; 9(2):87-92. PubMed ID: 12236317
[TBL] [Abstract][Full Text] [Related]
12. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis.
Matsui Y; Okamoto H; Jia N; Akino M; Uede T; Kitabatake A; Nishihira J
J Mol Cell Cardiol; 2004 Aug; 37(2):557-66. PubMed ID: 15276025
[TBL] [Abstract][Full Text] [Related]
13. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis.
Yuan Z; Liu Y; Liu Y; Zhang J; Kishimoto C; Wang Y; Ma A; Liu Z
Cardiovasc Res; 2003 Sep; 59(3):685-94. PubMed ID: 14499870
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion.
Yuan Z; Kishimoto C; Sano H; Shioji K; Xu Y; Yokode M
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H899-906. PubMed ID: 12860569
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway.
Haga T; Suzuki J; Kosuge H; Ogawa M; Saiki H; Haraguchi G; Maejima Y; Isobe M; Uede T
J Mol Cell Cardiol; 2009 May; 46(5):719-27. PubMed ID: 19233196
[TBL] [Abstract][Full Text] [Related]
17. A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation.
Futamatsu H; Suzuki J; Koga N; Adachi S; Kosuge H; Maejima Y; Haga T; Hirao K; Horuk R; Isobe M
J Mol Cell Cardiol; 2006 Jun; 40(6):853-61. PubMed ID: 16698032
[TBL] [Abstract][Full Text] [Related]
18. The effect of intravenous immunoglobulins on the progression of experimental autoimmune myocarditis in the rat.
George J; Barshack I; Malka E; Goldberg I; Keren P; Laniado S; Keren G
Exp Mol Pathol; 2001 Aug; 71(1):55-62. PubMed ID: 11502097
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of human monocyte activation via the 40-kDa Fc receptor for IgG.
MacIntyre EA; Roberts PJ; Abdul-Gaffar R; O'Flynn K; Pilkington GR; Farace F; Morgan J; Linch DC
J Immunol; 1988 Dec; 141(12):4333-43. PubMed ID: 2848894
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis.
Kamiyoshi Y; Takahashi M; Yokoseki O; Yazaki Y; Hirose S; Morimoto H; Watanabe N; Kinoshita O; Hongo M; Ikeda U
J Mol Cell Cardiol; 2005 Sep; 39(3):467-77. PubMed ID: 15978615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
